|Bid||0.00 x 800|
|Ask||0.00 x 1200|
|Day's range||0.00 - 0.00|
|Beta (3Y monthly)||0.34|
|PE ratio (TTM)||15.40|
|Forward dividend & yield||3.20 (6.47%)|
|1y target est||N/A|
Philip Morris International, the company behind Marlboro, is to spend another $100m this year developing its alternative to traditional cigarettes as a global marketing drive intensifies to convert smokers to a new generation of products. Martin King, chief financial officer, said on Thursday that extra funds would be deployed to accelerate innovation of the company’s IQOS product — a cigarette-like device that heats, rather than burns, tobacco. of IQOS in the US, are the latest sign of big tobacco ramping up investment to safeguard the industry’s future.
On Friday, Goldman Sachs upgraded Altria Group (MO) from a “neutral” to a “buy” while keeping its price target unchanged at $59.
Philip Morris' (PM) Q2 performance to gain from pricing and advancements in RRPs. However, low cigarette sales volumes are a worry.
Constellation Brands Inc (STZ), a leading producer and marketer of alcoholic beverage brands, is expected to release its Q1 fiscal 2020 earnings results before the bell this Friday, June 28. Our Zacks Consensus Estimate calls for quarterly EPS of $2.07.
As of June 21, Altria was trading at a forward PE ratio of 11.1x—compared to 12.8x before its first-quarter earnings were announced. Altria posted its first-quarter earnings on April 25.
Scott Gottlieb’s comments might have led to a fall in Altria’s stock price on June 21. At the closing on June 21, the company was trading at $48.00—a fall of 4.5% from the previous day’s closing price.
"They have so much historical youth use with their product," says Scott Gottlieb. "I don't know how Juul gets through an application process."